In addition, as suggested by recent studies on ENPP1 rs1044498 [35–37], a deeper knowledge of the genetic variants affecting the pathogenesis of T2D and related metabolic diseases may have important implications also for the implementation of tailored therapeutical approaches. This evidence concerns the gene ENPP1 and type 2 diabetes mellitus.